Light Therapy Intervention in Individuals With Parkinson's Disease

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 4, 2025

Primary Completion Date

January 29, 2026

Study Completion Date

July 30, 2026

Conditions
Parkinson Disease
Interventions
DEVICE

Red Light (PDT)

The intervention is a non invasive and safe practice. By delivering low level wavelength red light to the front part of the head, it can increase blood flow in the area treated and improve functioning of the associated regions, potentially improving symptoms.

DEVICE

Placebo

The intervention is a non invasive and safe practice. Participants will be wearing a helmet that delivered low level light therapy to the brain, and use it for the same amount of time as the treatment group. These participants will however, not receive the actual light and receive a placebo, so the helmet will be off. This is done to control of any potential positive effects of the therapy.

Trial Locations (1)

19711

RECRUITING

University of Delaware STAR Tower, Newark

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NeuroThera

INDUSTRY

lead

University of Delaware

OTHER